Journal of Neural Transmission

, Volume 115, Issue 7, pp 959–971 | Cite as

Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum

  • Mitsuko Hamamura
  • Naotsugu Hirata
  • Kazuhiko Sawada
  • Takahide Shuto
  • Takao Shimazoe
  • Yoshihiro Terada
  • Yasuyuki Fukumaki
Basic Neurosciences, Genetics and Immunology - Original Article

Abstract

The cerebellum has a parasagittal modular structure, in which Zebrin (Aldolase) positive and negative bands expressed in Purkinje cell layers alternate, and is involved in amphetamine psychosis. Administration of SKF38393, a D1 receptor agonist, reversed the behavioral sensitization of methamphetamine. In the vermis, there were the binding sites of SKF38393. In methamphetamine-sensitized rats the expression of the Aldolase mRNA positive bands move laterally in the rat vermis. We provide here the evidence that the D1 agonist injections also reversed the expression pattern of both the Aldolase mRNA in Purkinje cells and Ube (ubiquitin activating enzyme) 1x mRNA in Golgi interneurons of the sensitized rats. Thus the reverse changes in gene expression pattern in the vermis may be involved in the mechanisms of the behavioral plasticity and suggests the new treatment of drug abuse.

Keywords

Methamphetamine Dopamine agonists In situ hybridization Interneuron Neuronal plasticity 

References

  1. Abbott LC, Isaacs KR, Heckroth JA (1996) Co-localization of tyrosine hydroxylase and zebrin II immunoreactivities in Purkinje cells of the mutant mice, tottering and tottering/leaner. Neuroscience 71:461–475PubMedCrossRefGoogle Scholar
  2. Anderson CM, Teicher MH, Polcari A, Renshaw PF (2002) Abnormal T2 relaxation time in the cerebellar vermis of adults sexually abused in childhood: potential role of the vermis in stress-enhanced risk for drug abuse. Psychoneuroendocrinology 27:231–244PubMedCrossRefGoogle Scholar
  3. Anderson CM, Maas LC, Frederick B, Bendor JT, Spencer TJ, Livni E, Lukas SE, Fischman AJ, Madras BK, Renshaw PF, Kaufman MJ (2006) Cerebellar vermis involvement in cocaine-related behaviors. Neuropsychopharmacology 31:1318–1326PubMedCrossRefGoogle Scholar
  4. Barik S, de Beaurepaire R (2005) Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Prog Neuropsychopharmacol Biol Psychiatry 29:718–726PubMedCrossRefGoogle Scholar
  5. Bartoletti M, Gubellini C, Ricci F, Gaiardi M (2004) The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behavioural Pharmacology 15:397–401PubMedCrossRefGoogle Scholar
  6. Bartoletti M, Gubellini C, Ricci F, Gaiardi M (2005) Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav Pharmacol 16:553–558PubMedCrossRefGoogle Scholar
  7. Blazquez PM, Fujii N, Kojima J, Graybiel AM (2002) A network representation of response probability in the striatum. Neuron 33:973–982PubMedCrossRefGoogle Scholar
  8. Boegman RJ, Parent A, Hawkes R (1988) Zonation in the rat cerebellar cortex: patches of high acetylcholinesterase activity in the granular layer are congruent with Purkinje cell compartments. Brain Res 448:237–251PubMedCrossRefGoogle Scholar
  9. Bolsover SR, Gilbert SH, Spector I (1992) Intracellular cyclic AMP produces effects opposite to those of cyclic GMP and calcium on shape and motility of neuroblastoma cells. Cell Motil Cytoskeleton 22:99–116PubMedCrossRefGoogle Scholar
  10. Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. J Cereb Blood Flow Metab 17:437–447PubMedGoogle Scholar
  11. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65–79PubMedCrossRefGoogle Scholar
  12. Douglass J, Daoud S (1996) Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene 169:241–245PubMedCrossRefGoogle Scholar
  13. Dusart I, Morel MP, Sotelo C (1994) Parasagittal compartmentation of adult rat Purkinje cells expressing the low-affinity nerve growth factor receptor: changes of pattern expression after a traumatic lesion. Neuroscience 63:351–356PubMedCrossRefGoogle Scholar
  14. Edwards MA, Crandall JE, Leclerc N, Yamamoto M (1994) Effects of nervous mutation on Purkinje cell compartments defined by Zebrin II and 9-O-acetylated gangliosides expression. Neurosci Res 19:167–174PubMedCrossRefGoogle Scholar
  15. Eisenman LM, Hawkes R (1993) Antigenic compartmentation in the mouse cerebellar cortex: zebrin and HNK-1 reveal a complex, overlapping molecular topography. J Comp Neurol 335:586–605PubMedCrossRefGoogle Scholar
  16. Fletcher PJ, Tenn CC, Sinyard J, Rizos Z, Kapur S (2007) A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology 32:1122–1132PubMedCrossRefGoogle Scholar
  17. Fonseca R, Vabulas RM, Hartl FU, Bonhoeffer T, Nagerl UV (2006) A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP. Neuron 52:239–245PubMedCrossRefGoogle Scholar
  18. Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, Capobianco L, Battaglia G, De Blasi A, Nicoletti F, Paparelli A (2004) Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J Neurochem 88:114–123PubMedCrossRefGoogle Scholar
  19. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A (1996) Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 93:12040–12045PubMedCrossRefGoogle Scholar
  20. Hamamura M, Leng G, Emson PC, Kiyama H (1991) Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin. J Physiol (Lond) 444:51–63Google Scholar
  21. Hamamura M, Ozawa H, Kimuro Y, Okouchi J, Higasa K, Iwaki A, Fukumaki Y (1999) Differential decreases in c-fos and aldolase C mRNA expression in the rat cerebellum after repeated administration of methamphetamine. Brain Res Mol Brain Res 64:119–131PubMedCrossRefGoogle Scholar
  22. Hamamura M, Watanabe S, Fukumaki Y (2004) Selective changes in the shapes of parasagittal bands of Aldoc (Zebrin) mRNA in the rat vermis of the cerebellum after repeated methamphetamine injections. Cerebellum 3:236–247PubMedCrossRefGoogle Scholar
  23. Hansel C, Linden DJ (2002) Beyond parallel fiber LTD: the diversity of synaptic and non-synaptic plasticity in the cerebellum. Nat Neurosci 5:725–726PubMedCrossRefGoogle Scholar
  24. Hawkes R, Leclerc N (1989) Purkinje cell axon collateral distributions reflect the chemical compartmentation of the rat cerebellar cortex. Brain Res 476:279–290PubMedCrossRefGoogle Scholar
  25. Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi M, Chain DG, Martin KC, Kandel ER, Schwartz JH (1997) Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89:115–126PubMedCrossRefGoogle Scholar
  26. Holtzman T, Rajapaksa T, Mostofi A, Edgley SA (2006) Different responses of rat cerebellar Purkinje cells and Golgi cells evoked by widespread convergent sensory inputs. J Physiol 574:491–507PubMedCrossRefGoogle Scholar
  27. Huang Q, Zhou D, Chase K, Gusella JF, Aronin N, DiFiglia M (1992) Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Natl Acad Sci USA 89:11988–11992PubMedCrossRefGoogle Scholar
  28. Imai N, Kaneda S, Nagai Y, Seno T, Ayusawa D, Hanaoka F, Yamao F (1992) Cloning and sequence of a functionally active cDNA encoding the mouse ubiquitin-activating enzyme E1. Gene 118:279–282PubMedCrossRefGoogle Scholar
  29. Ito M (1986) Long-term depression as a memory process in the cerebellum. Neurosci Res 3:531–539PubMedCrossRefGoogle Scholar
  30. Ito M (2006) Cerebellar circuitry as a neuronal machine. Prog Neurobiol 78:272–303PubMedCrossRefGoogle Scholar
  31. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. (see comment). Neuron 21:799–811PubMedCrossRefGoogle Scholar
  32. Jurjus GJ, Weiss KM, Jaskiw GE (1994) Schizophrenia-like psychosis and cerebellar degeneration. Schizophr Res 12:183–184PubMedCrossRefGoogle Scholar
  33. Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, Goldman-Rakic PS (1998) Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 95:7731–7736PubMedCrossRefGoogle Scholar
  34. King-Smith C, Basciano PA, Pham NB (2001) Effects of the actin-stabilizing drug, jasplakinolide, on pigment granule motility in isolated retinal pigment epithelial (RPE) cells of green sunfish, Lepomis cyanellus. Pigment Cell Res 14:14–22PubMedCrossRefGoogle Scholar
  35. Kuribara H, Tadokoro S (1990) Effects of YM-09151–2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice. Japn J Pharmacol 52:489–492CrossRefGoogle Scholar
  36. Kuribara H, Uchihashi Y (1994) Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 47:101–106PubMedCrossRefGoogle Scholar
  37. Martin-Solch C, Magyar S, Kunig G, Missimer J, Schultz W, Leenders KL (2001) Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study. Exp Brain Res 139:278–286PubMedCrossRefGoogle Scholar
  38. Mehler C, Warnke A (2002) Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. J Neural Transm 109:219–234PubMedCrossRefGoogle Scholar
  39. Melchitzky DS, Lewis DA (2000) Tyrosine hydroxylase- and dopamine transporter- immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation. Neuropsychopharmacology 22:466–472PubMedCrossRefGoogle Scholar
  40. Mitchell SJ, Silver RA (2000) GABA spillover from single inhibitory axons suppresses low-frequency excitatory transmission at the cerebellar glomerulus. J Neurosci 20:8651–8658 PubMedGoogle Scholar
  41. Morales B, Choi SY, Kirkwood A (2002) Dark rearing alters the development of GABAergic transmission in visual cortex. J Neurosci 22:8084–8090PubMedGoogle Scholar
  42. Nagao S, Kwak S, Kanazawa I (1997) EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in Purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum. Neuroscience 78:929–933PubMedCrossRefGoogle Scholar
  43. Nieoullon A, Cheramy A, Glowinski J (1978) Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat. Brain Res 148:143–152PubMedCrossRefGoogle Scholar
  44. Nunez DJ, Brown MJ, Davenport AP (1989) Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. Clin Sci 77:129–131PubMedGoogle Scholar
  45. Ozol K, Hayden JM, Oberdick J, Hawkes R (1999) Transverse zones in the vermis of the mouse cerebellum. J Comp Neurol 412:95–111PubMedCrossRefGoogle Scholar
  46. Panagopoulos NT, Matsokis NA, Valcana T (1993) Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations. J Neurosci Res 35:499–506PubMedCrossRefGoogle Scholar
  47. Pickart CM (2001) Ubiquitin enters the new millennium. Annu Rev Biochem 70:503–533PubMedCrossRefGoogle Scholar
  48. Pinaud R, Velho TA, Jeong JK, Tremere LA, Leao RM, von Gersdorff H, Mello CV (2004) GABAergic neurons participate in the brain’s response to birdsong auditory stimulation. Eur J Neurosci 20:1318–1330PubMedCrossRefGoogle Scholar
  49. Ribeiro S, Cecchi GA, Magnasco MO, Mello CV (1998) Toward a song code: evidence for a syllabic representation in the canary brain. Neuron 21:359–371PubMedCrossRefGoogle Scholar
  50. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157–198PubMedCrossRefGoogle Scholar
  51. Sandyk R, Kay SR, Merriam AE (1991) Atrophy of the cerebellar vermis: relevance to the symptoms of schizophrenia. Int J Neurosci 57:205–212PubMedCrossRefGoogle Scholar
  52. Santiago MF, Costa MR, Mendez-Otero R (2004) Immunoblockage of 9-O-acetyl GD3 ganglioside arrests the in vivo migration of cerebellar granule neurons. J Neurosci 24:474–478PubMedCrossRefGoogle Scholar
  53. Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, Nishi A, Yamamoto T (2006) Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist. Neuropharmacology 50:991–997PubMedCrossRefGoogle Scholar
  54. Sokolov BP, Jiang L, Trivedi NS, Aston C (2003) Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 72:756–767PubMedCrossRefGoogle Scholar
  55. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. Neuroimage 24:6028–6036Google Scholar
  56. Touri F, Hawkes R, Riederer BM (1996) Differential distribution of MAP1a and aldolase c in adult mouse cerebellum. Eur J Neurosci 8:61–68PubMedCrossRefGoogle Scholar
  57. Tremere L, Hicks TP, Rasmusson DD (2001) Role of inhibition in cortical reorganization of the adult raccoon revealed by microiontophoretic blockade of GABA(A) receptors. J Neurophysiol 86:94–103PubMedGoogle Scholar
  58. Velho TA, Lovell P, Mello CV (2007) Enriched expression and developmental regulation of the middle-weight neurofilament (NF-M) gene in song control nuclei of the zebra finch. J Comp Neurol 500:477–497PubMedCrossRefGoogle Scholar
  59. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM (2003) Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosc 23:11461–11468Google Scholar
  60. Williams S, Mmbaga N, Chirwa S (2006) Dopamine D1 receptor agonist SKF 38393 induces GAP-43 expression and long-term potetiation in hippocampus in vivo. Neurosci Lett 402:46–50PubMedCrossRefGoogle Scholar
  61. Wood MA, Kaplan MP, Brensinger CM, Guo W, Abel T, Woodruff CC (2005) Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory Content-specificity of the neural correlates of recollection. Hippocampus 15:610–621PubMedCrossRefGoogle Scholar
  62. Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2003) Dopamine as a novel anti- migration factor of vascular smooth muscle cells through D1A and D1B receptors. J Cardiovasc Pharmacol 41(Suppl 1):S33–38PubMedGoogle Scholar
  63. Zheng W, Knudsen EI (1999) Functional selection of adaptive auditory space map by GABA A-mediated inhibition. Science 284:962–965PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Mitsuko Hamamura
    • 1
    • 2
  • Naotsugu Hirata
    • 2
  • Kazuhiko Sawada
    • 4
  • Takahide Shuto
    • 3
  • Takao Shimazoe
    • 3
  • Yoshihiro Terada
    • 1
  • Yasuyuki Fukumaki
    • 2
  1. 1.Department of Fixed Prosthetics, Graduate School of Dental SciencesKyushu UniversityFukuokaJapan
  2. 2.Division of Disease Genes, Research Center for Genetic Information, Institute of Bio-RegulationKyushu UniversityFukuokaJapan
  3. 3.Department of Pharmacology, Graduate School of Pharmaceutical SciencesKyushu UniversityFukuokaJapan
  4. 4.Department of Anatomy and Developmental NeurobiologyUniversity of Tokushima Graduate School Institute of Health BiosciencesTokushimaJapan

Personalised recommendations